General Information of Drug (ID: DMCXZ9L)

Drug Name
3-hydroxyquinazoline-2,4(1H,3H)-dione Drug Info
Synonyms
3-hydroxyquinazoline-2,4(1H,3H)-dione; 3-hydroxy-quinazoline-2,4-dione; CHEMBL183852; 5329-43-1; NSC2552; AC1Q6JF3; AC1L58DP; N-hydroxy quinazolinedione, 4; SCHEMBL1520708; 3-hydroxyquinazoline-2,4-dione; CTK4J7468; BDBM33412; DTXSID00277492; ZINC1640999; NSC-2552; 3-hydroxy-1H-quinazoline-2,4-dione; 3-HYDROXY-2,3H)-QUINAZOLINEDIONE
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
220188
CAS Number
CAS 5329-43-1
TTD Drug ID
DMCXZ9L

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-hydroxyisoquinoline-1,3(2H,4H)-dione DMTLYDS Discovery agent N.A. Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Human immunodeficiency virus Ribonuclease H (HIV RNH) TT37KAF POL_HV1B1 Inhibitor [1]

References

1 RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information. J Med Chem. 2009 Oct 8;52(19):5781-4.